Surgery Partners to Go Private in a $5.7 Billion Deal

Surgery Partners Inc. is set to be acquired by an affiliate of Bon Secours Mercy Health, the U.S.-based organization abbreviated BSMH, at an enterprise value of $5.7 billion. The buyer has agreed to pay $23.50 per share, according to the HealthSpan Partners announcement.

Those two numbers measure different things. Enterprise value is the equity price plus net debt, where net debt is borrowing minus cash on hand. So the $5.7 billion headline reflects the whole capital structure, while $23.50 is what common shareholders receive for each share. Anyone comparing the deal with public trading levels should keep that distinction in view.

The acquiring entity is named HealthSpan Partners. The transaction will take Surgery Partners private, according to Yahoo Finance, which removes the company's shares from public markets. Affiliates of Bain Capital, which holds a nearly 40 percent stake, will roll over their shares in exchange for equity interests in the acquiring entity. A rollover defers the cash exit: Bain's affiliates keep economic exposure to the business under new ownership instead of receiving proceeds at closing.

The terms are higher than the figures reported before the announcement. Bloomberg, citing the Financial Times, reported on October 25 that Bon Secours was nearing a near-$6 billion purchase valuing the group at about $20 a share. The $23.50 price is roughly 17.5 percent above that $20 level. The $5.7 billion enterprise value sits below the near-$6 billion figure in that reporting.

The operating footprint is large. Surgery Partners' website describes more than 300 locations across 30 states, more than 16,000 employees, 5,000 affiliated physicians, and more than 670,000 patients served annually. Its ancillary services include multi-specialty physician practices and anesthesia services. Those facilities, physician relationships, and anesthesia coverage form the asset base behind the release's stated aim of establishing a leading outpatient surgical care platform, meaning a network of procedures performed without an overnight hospital stay.

In my view, the structure matters as much as the price. A take-private at a $5.7 billion enterprise value, with a large existing holder rolling into the buyer, changes who bears the risk and who collects the upside after closing. Because Bain's affiliates tie their stake to HealthSpan's equity, the sponsor's return depends on how the platform performs under new ownership, not on the $23.50 figure alone. Anyone tracking the deal should watch how the equity and debt are financed, since the announcement's headline figures do not show that split.

For patients and employees, the immediate effect is continuity of a large network that has now been announced for sale, with its ownership set to move from public shareholders to a private group. The announcement does not describe changes to clinical operations.